Home / David L. Joffe, BSPharm, CDE, FACA (page 41)

David L. Joffe, BSPharm, CDE, FACA

(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

December 5, 2015

21, 28, 30, 90. What do these numbers mean? For many of us they are the number of days before leftover insulin has to be thrown away. As a pharmacist it often amazes me what patients think they should do. If you need the quick answer for your patients be …

Read More »

When we talk about the causes of diabetes we know it is not just one thing; in fact the Ominous Octet is a phrase that is often used to describe the defects that play a role in diabetes. The first and most well-known of these is insulin resistance. In fact …

Read More »

November 28, 2015

Those of us in the U.S. celebrated Thanksgiving this week. One of the things the DIC team has to be thankful for is our wonderful readers. We’re grateful for your loyal readership and especially for the great feedback and content, like our weekly Disasters Averted stories, you send us. We …

Read More »

When you do the math, 95% of all diabetes patients have type 2. This does not mean that we should ignore type 1 patients when looking at psychological problems; in fact, most of the information on these problems deals with type 1 patients. These problems can include development of diabetes, …

Read More »

November 21, 2015

Diabetes educators often have mixed emotions about the use of artificially sweetened food products. On the one hand the reduction of glucose-raising sweeteners offers our patients a way to enjoy the tastes they like and still reduce calorie and carb consumption. On the flip side we often wonder if these …

Read More »

November 14, 2015

Oftentimes we are challenged to start a patient with prediabetes on a diabetes drug. We never are sure if that is the right thing to do. This week, we have the results of a 3-year study using the active ingredient in a popular diabetes drug in patients who have not …

Read More »

When we have insulin-using diabetes patients, we sometimes fall into the trap of thinking the patient knows as much as we do and has become an expert in their own care. This usually leads to problems that appear to be severe, but can be broken down into simple solutions. With …

Read More »

November 12, 2015

There are many studies going on looking at the side effects of medications for every disease state. Most of these occur after the drugs are on the market and more people are using them. One of the problems that can occur in these postmarking studies is the lack of good controls …

Read More »

November 7, 2015

Oftentimes when an insulin using patient is admitted to the hospital they are kept on the same insulin product and regimen they arrived with. For many patients this works well but for those using mixed insulin there appears to be an increased incidence of hypoglycemia. This could be because of …

Read More »

October 31, 2015

There has been a lot of press concerning the use of SGLT-2 Inhibitors and the possibility of DKA. Logically speaking it would seem that anything that lowers glucose would be of benefit in preventing DKA, but for some reason the human body seems to defy logic. With this in mind …

Read More »